• Consolidated revenues up by 18%, EBITDA by 19% and PBT by 27%. Reported PAT grew by 125%, after providing for exceptional expenses of Rs.46 crores...
Claris Lifesciences Ltd. today announced its quarterly and half yearly un-audited financial results for the quarter and half year ended 30th June 2014 at its board meeting held at its registered office in Ahmedabad.
Editors’ Synopsis
For the Quarter ended June 30, 2014:
Total Income stood at Rs. 739.8 crore in Q1FY15, up by 24.62% compared to Rs. 593.4 crore in Q1FY14;
Net p...
Consolidated Total Income for Q1FY15 increased by 104% to Rs 5248 crore Vs Rs 2,572 crore in Q1FY14
Consolidated EBIDTA for Q1FY15 increased by 227% to Rs 1645 crore Vs Rs 504 crore in Q1FY1...
